In our previous article How to Win Market Share from Your Competitors, we discussed why developing a dedicated customer experience strategy is so critical to success for life science companies. It is important particularly for those looking to increase customer loyalty or steal market share for competitors in maturing markets. As mentioned, key touchpoints during […]
Life science companies are competing in a time of increased consolidation, with modest growth in steadily maturing markets. Although there are recent exceptions, such as the rise of genome editing products, these conditions virtually dictate that in order to grow, life science companies must win market share from their competitors. A key component for winning […]
Many from our BioInformatics team hit the exhibit floor at AACR, and they’ve shared some of their insights! Attendance increased around 3% this year to more than 22,600. The number of exhibitors jumped 11.8% to 556. The meeting’s presentations and exhibits showed clear enthusiasm for progress in personalized medicine and immumno-oncology.
At BioInformatics Inc. we have the opportunity to explore many different markets on behalf of our clients. In this article we discuss the $50 million market for compact image-based cell analyzers. Broadly, cytometers refer to instruments that can measure various characteristics of cell populations in suspension. Depending on which and how many characteristics or parameters […]
In this article we discuss some of the product categories covered by the SDi Global Assessment Report 2018: The Laboratory Analytical & Life Science Instrumentation Industry. The SDi Global Report is comprised of ten major sections, each devoted to a major class of instrumentation. Here’s what manufacturers can expect in 2018. Chromatography: Mobile and High […]
On Friday March 16, 2018, the Centers for Medicare & Medicaid Services (CMS) took action to advance innovative personalized medicine for Medicare patients with cancer. CMS announced it has finalized a National Coverage Determination that covers diagnostic laboratory tests using Next Generation Sequencing (NGS) for patients with advanced cancer. This decision is likely to accelerate […]
BioInformatics Inc., the leading market research firm supporting the analytical instrumentation and life science industries, and owner of The Science Advisory Board®, is pleased to announce the acquisition of IMV Publishing. This latest acquisition by BioInformatics Inc. creates an integrated business information and media group delivering high-value content to the market’s buyers and sellers using […]
In our Global Assessment series, we’ve already covered many exciting technologies and topics, such as portable spectroscopy machines, NGS, Triple quadrupole ICP-MS, atomic spectroscopy, and their respective roles in the industry. Today our analyst, Ivan, will give us some insight into the role of chromatography in cannabis testing.
Strategic Directions International (SDi), a division of BioInformatics Inc., just released the SDi Global Assessment Report 2018: The Laboratory Analytical & Life Science Instrumentation Industry. In this article we discuss some of key trends we observed in 2018 and our analysis of where the industry will find opportunities for growth in 2018. The 800+ page […]
The day you’ve all been waiting for has FINALLY arrived: The gold standard of market research, the 2018 SDi Global Assessment Report, is officially available!
